Published in AIDS on July 31, 2012
Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis (2015) 2.96
The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30
Aging with HIV in Africa: the challenges of living longer. AIDS (2012) 1.21
Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. J Gen Intern Med (2013) 0.92
A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients. Infect Dis Ther (2015) 0.90
Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa. PLoS One (2014) 0.84
Polypharmacy in the HIV-infected older adult population. Clin Interv Aging (2013) 0.83
Clinical pharmacokinetics of antiretroviral drugs in older persons. Expert Opin Drug Metab Toxicol (2013) 0.83
Cardiovascular disease risk in an aging HIV population: not just a question of biology. Curr Opin HIV AIDS (2014) 0.82
Total daily pill burden in HIV-infected patients in the southern United States. AIDS Patient Care STDS (2014) 0.79
Sexual risk behaviors and HIV risk among Americans aged 50 years or older: a review. Subst Abuse Rehabil (2015) 0.78
A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV. HIV AIDS (Auckl) (2013) 0.78
Comorbidities among the HIV-infected patients aged 40 years or older in Taiwan. PLoS One (2014) 0.77
Fall frequency and associated factors among men and women with or at risk for HIV infection. HIV Med (2016) 0.76
Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population. Clin Interv Aging (2016) 0.76
Pill Burden Influences the Association Between Time-Based Prospective Memory and Antiretroviral Therapy Adherence in Younger But Not Older HIV-Infected Adults. J Assoc Nurses AIDS Care (2016) 0.75
Age patterns of Kaposi's sarcoma incidence in a cohort of HIV-infected men. Cancer Med (2014) 0.75
HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors. PLoS One (2015) 0.75
Results of a doravirine-atorvastatin drug-drug interaction study. Antimicrob Agents Chemother (2016) 0.75
Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study. PLoS One (2017) 0.75
Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med (2017) 3.90
Current status and future prospects of epidemiology and public health training and research in the WHO African region. Int J Epidemiol (2012) 3.60
Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: A meta-analysis of randomized controlled trials. Clin Infect Dis (2014) 2.65
Antiretroviral medication errors remain high but are quickly corrected among hospitalized HIV-infected adults. Clin Infect Dis (2012) 2.24
The challenge of managing drug interactions in elderly people. Lancet (2007) 2.19
Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis. PLoS One (2012) 2.09
HIV infection-related tuberculosis: clinical manifestations and treatment. Clin Infect Dis (2010) 2.02
Severe prolonged sedation associated with coadministration of protease inhibitors and intravenous midazolam during bronchoscopy. Pharmacotherapy (2012) 2.01
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults. Cochrane Database Syst Rev (2010) 1.94
Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev (2012) 1.77
Antiretroviral treatment strategies in highly treatment experienced perinatally HIV-infected youth. Pediatr Infect Dis J (2012) 1.62
Outcomes of children with enterobacteriaceae bacteremia with reduced susceptibility to ceftriaxone: do the revised breakpoints translate to improved patient outcomes? Pediatr Infect Dis J (2013) 1.55
Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015. Lancet HIV (2016) 1.51
A review of the toxicity of HIV medications. J Med Toxicol (2014) 1.19
Risk factors and a predictive model for under-five mortality in Nigeria: evidence from Nigeria demographic and health survey. BMC Pregnancy Childbirth (2012) 1.12
Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging (2012) 1.10
Individual and contextual factors associated with childhood stunting in Nigeria: a multilevel analysis. Matern Child Nutr (2011) 1.09
Medication appropriateness index: reliability and recommendations for future use. J Am Geriatr Soc (2006) 1.06
A bibliometric analysis of childhood immunization research productivity in Africa since the onset of the Expanded Program on Immunization in 1974. BMC Med (2013) 0.94
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons. Clin Infect Dis (2012) 0.93
Organization of the medication management process in Belgian nursing homes. J Am Med Dir Assoc (2010) 0.89
Prevalence of Hypertension in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2015) 0.89
Factors that affect the uptake of community-based health insurance in low-income and middle-income countries: a systematic protocol. BMJ Open (2014) 0.89
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. Expert Rev Anti Infect Ther (2010) 0.89
The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol. BMJ Open (2014) 0.88
Pattern and determinants of HIV research productivity in sub-Saharan Africa: bibliometric analysis of 1981 to 2009 PubMed papers. BMC Infect Dis (2010) 0.88
Exploring variations in childhood stunting in Nigeria using league table, control chart and spatial analysis. BMC Public Health (2013) 0.88
The impact of mass media interventions on tuberculosis awareness, health-seeking behaviour and health service utilisation: a systematic review protocol. BMJ Open (2014) 0.85
2012 updated Beers Criteria: greater applicability to Europe? J Am Geriatr Soc (2012) 0.85
Does the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia? Clin Infect Dis (2012) 0.85
Tenofovir for the treatment of hepatitis B virus. Pharmacotherapy (2009) 0.84
Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 0.83
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women. Cochrane Database Syst Rev (2011) 0.83
Less is more: combination antibiotic therapy for the treatment of gram-negative bacteremia in pediatric patients. JAMA Pediatr (2013) 0.82
Expanded access drug profile: raltegravir (RAL, MK-0518). Hopkins HIV Rep (2007) 0.82
Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden? Patient Prefer Adherence (2011) 0.80
Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call. J AIDS Clin Res (2013) 0.79
Drug profile: fosamprenavir (Lexiva). Hopkins HIV Rep (2003) 0.79
Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital. Ann Pharmacother (2013) 0.79
Social disorganization and history of child sexual abuse against girls in sub-Saharan Africa: a multilevel analysis. BMC Int Health Hum Rights (2013) 0.79
Raltegravir-induced cerebellar ataxia. AIDS (2010) 0.79
FDA approves Aptivus (tipranavir). Hopkins HIV Rep (2005) 0.78
Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens. AIDS (2016) 0.78
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children. Curr Opin Infect Dis (2014) 0.78
Initiatives promoting seamless care in medication management: an international review of the grey literature. Int J Clin Pharm (2013) 0.78
[Continuity in patient care upon hospital discharge: evaluation of a clinical pharmacy discharge form for community pharmacists]. J Pharm Belg (2008) 0.77
Content validity and inter-rater reliability of an instrument to characterize unintentional medication discrepancies. Drugs Aging (2012) 0.76
Preventive strategies against bleeding due to nonvitamin K antagonist oral anticoagulants. Biomed Res Int (2014) 0.76
[Why, when and how to monitor new oral anticoagulants]. Rev Med Suisse (2014) 0.76
Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Cochrane Database Syst Rev (2013) 0.76
Meta-analysis of randomized controlled trials on the treatment of pulmonary arterial hypertension. Circ J (2010) 0.75
Individual and community-level socioeconomic position and its association with adolescents experience of childhood sexual abuse: a multilevel analysis of six countries in Sub-Saharan Africa. J Inj Violence Res (2013) 0.75
Authors' reply. Pharmacotherapy (2012) 0.75
Drug-induced lithium intoxication: a case report. J Am Geriatr Soc (2005) 0.75
Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' reply. Ann Pharmacother (2015) 0.75
Drug profile: enfuvirtide (Fuzeon, ENF, T-20). Hopkins HIV Rep (2003) 0.75
[Potentially inappropriate medication use in elderly care in Burkina Faso]. Sante Publique (2016) 0.75
Drug profile: telbivudine (Tyzeka). Hopkins HIV Rep (2007) 0.75
Review of the cost-effectiveness of interventions to improve seamless care focusing on medication. Int J Clin Pharm (2011) 0.75
Drug profile: atazanavir (Reyataz, ATV). Hopkins HIV Rep (2003) 0.75
Drug substitution associated with a hospital stay in Belgium: a retrospective analysis of a claims database. Int J Pharm Pract (2013) 0.75
Interventions for HIV-associated nephropathy. Cochrane Database Syst Rev (2013) 0.75
Tenofovir disoproxil fumarate (Viread) for the treatment of HIV infection. Expert Rev Anti Infect Ther (2003) 0.75
The Burden of Hypertension in an Oil- and Gas-Polluted Environment: A Comparative Cross-Sectional Study. Am J Hypertens (2016) 0.75
[Evaluation of the quality of counseling provided by community pharmacists to pregnant women]. J Pharm Belg (2010) 0.75
Safety of Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy Regimens in Pregnancy for HIV-Infected Women and Their Infants: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr (2017) 0.75
Expanded drug access: etravirine (formerly TMC-125). Hopkins HIV Rep (2007) 0.75
Long-term Virologic Suppression Despite Presence of Resistance-associated Mutations Among Perinatally HIV-infected Youth. Pediatr Infect Dis J (2015) 0.75